Company / Capital Expenditures
ACCENDRA HEALTH INC/VA/ Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$191.0M
FY2025
5-year range
$42.4M / $191.0M
FY2021-FY2025
Trend
+12.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 10 years, ranging from $20M in FY2016 to $191M in FY2025.
Based on SEC 10-K filings.
$191M in FY2025 with a 5-year CAGR of +30.5%.
Improved from $172M to $191M over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +6.5%
- 5-Year CAGR
- +30.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +30.5%, indicating consistent growth.
- In FY2025, capital expenditures increased 12.1% year-over-year.
- Lowest capital expenditures in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $191.0M | +12.1% |
| FY2024 | $170.3M | -1.2% |
| FY2023 | $172.4M | +9.0% |
| FY2022 | $158.1M | +272.7% |
| FY2021 | $42.4M | -15.9% |
| FY2020 | $50.4M | +12.4% |
| FY2019 | $44.9M | +0.0% |
| FY2018 | $44.9M | +29.6% |
| FY2017 | $34.6M | +70.5% |
| FY2016 | $20.3M | -1.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026